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Abstract 
 
BACKGROUND: The extraction of biopharmaceuticals from plasma and serum often employs 
overly complicated antiquated procedures, that can inflict serious damage on especially prone protein 
targets and which afford low purification power and overall yields. Here we describe systematic 
development of a high-gradient magnetic fishing process for recovery of immunoglobulins from 
unclarified antiserum. 
 
RESULTS: Non-porous superparamagnetic particles were transformed into hydrophobic-charge 
induction adsorbents and then used to recover immunoglobulins from rabbit antiserum feedstocks. 
Comprehensive characterisation tests conducted with variously diluted clarified antiserum on a 
magnetic rack revealed that immunoglobulin binding was rapid (equilibrium reached in <45 s), strong 
(Kd <0.1 mg mL-1), of high capacity (Qmax = 214 mg g-1), and pH and ionic strength dependent. In a 
high-gradient magnetic fishing process conducted with the same adsorbent, and a conventional 
‘magnetic filter + recycle loop’ arrangement, >72% of the immunoglobulin present in an unclarified 
antiserum feed was recovered in 0.5 h in >3-fold purified form. 
 
CONCLUSIONS: Fast magnetic particle based capture of antibodies from an unclarified high-titre 
feed has been demonstrated. Efficient product recovery from ultra-high titre bioprocess liquors by 
high-gradient magnetic fishing requires that improved magnetic adsorbents displaying high 
selectivity, ultra-high capacity and operational robustness are used with 'state-of-the-art’ rotor-stator 
magnetic separators. 
 
INTRODUCTION 
The markets from blood-derived protein products are large, and growing, albeit not fast enough to 
meet escalating global needs.1,2 Among recognised factors hindering growth are: increased 
competition from recombinant alternatives; high cost and limited procurement of pooled plasma 
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starting material, meaning that several therapeutic products must be extracted from the same pool; and 
continued reliance on antiquated overly expensive and complex production processes.2,3 
Outdated purification methods also persist within the immunodiagnostics sector and in large 
scale commercial processing of animal plasmas. For example, multiple steps of ammonium sulphate 
precipitation, dialysis and ion exchange batch adsorption are commonly employed in the production 
of polyclonal antibodies from serum for diagnostic kit applications,4–6 and harsh precipitation 
principles are likewise common in recovery operations for target proteins from equine plasmas, often 
compromising the extraction of other protein products.7–9  
Immunoglobulins are currently the most important blood-derived product, accounting for nearly 
50% of the global plasma proteins market (cf. 10 – 15% each for plasma-derived Factor VIII and 
albumin), but their recovery (by multiple precipitation steps followed by ion exchange 
chromatography) incurs large losses during precipitation.3,10,11 In recognition of this, and in response 
to increasing market demands for polyclonal immunoglobulins as biotherapeutics, new approaches 
(largely chromatographic), able to simultaneously improve product recovery, purity and productivity, 
are gradually replacing the three step ethanol fractionation process.3,10,11  
Ion exchange is the preferred chromatographic technique for commercial recovery and 
purification of polyclonal antibody therapeutics from human plasma.10 Protein A affinity 
chromatography, the lynchpin purification technique in industrial manufacture production of clinical 
grade monoclonal antibodies,12 is not employed and neither is Protein G affinity chromatography.3,10 
Protein A fails to bind all human IgG subclasses, particularly IgG3, which contributes to the humoral 
viral defence. Protein G on the other hand binds all subclasses of IgG, but the strongly acidic elution 
conditions required are too harsh for a subpopulation of polyclonal human IgG.10 Additional negating 
factors for chromatography on Protein A/G columns are potential ligand leaching10 concerns, and 
unacceptably high media costs10,13 for purifying huge quantities of polyclonal antibodies (global 
production of intravenous immunoglobulins reached 140 tonnes in 201413). 
Though well adapted to the fractionation and polishing of pre-purified plasma fractions and 
processing of monoclonal antibody culture supernatants, fixed bed chromatography is less well suited 
to product capture from much more complex plasma and serum feeds.9,14 The presence of troublesome 
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fouling components within these feeds, especially suspended lipoproteinaceous materials, can 
severely compromise chromatographic operations; the extent to which this occurs is largely governed 
by the nature of the immobilised ligand and that of base matrix to which it is attached.5,6,15  
The requirement for extensive clarification prior to loading biological feedstocks on fixed bed 
chromatography columns is essential, as suspended solids within them become trapped in the 
interstitial space between media particles, rapidly cutting off liquid flow through the bed and posing 
unacceptable demands on CIP/SIP. In stark contrast, modern direct capture techniques, such as 
expanded bed adsorption and high-gradient magnetic fishing (HGMF), are suited to fast recovery of 
target species from large volumes of unclarified biological liquors,15–18 afford potential improvements 
in product yield, productivity and process efficiency cf. conventional clarification followed by fixed 
bed chromatography, and importantly, both methods have been successfully applied for product 
recovery from plasma/serum feeds.9,14 HGMF, a scaleable technique combining adsorption of a 
product of interest on to low-cost functionalised magnetic particles, with subsequent retrieval and 
processing of the product laden magnetic support by means of high-gradient magnetic separation 
(HGMS) technology,18–21 affords a fast and efficient means for isolating protein products from crude 
feedstocks.9,15,18,21–27  
Here we describe systematic development of an HGMF process for the capture and purification 
of polyclonal antibodies from an unclarified rabbit antiserum feedstock, employing non-porous 
superparamagnetic adsorbents functionalised with the hydrophobic-charge induction ligand, 4-
mercaptoethylpyridine (4-MEP). The choice of 4-MEP as ligand was informed by a previous study,6 
in which we compared the suitability of eight commercial chromatography media intended for 
antibody purification, for capture and purification of polyclonal immunoglobulins from complex 
clarified rabbit antiserum feeds. Of the five low molecular class synthetic ligand based media tested, 
only the hydrophobic charge induction matrix MEP HyperCel compared favourably with the much 
more expensive rProtein A based media.  
Four different activation routes were employed for anchoring 4-MEP to a favoured magnetic 
support particle. The resulting adsorbents were subsequently screened in small-scale magnetic rack 
tests for their ability to purify immunoglobulins from a clarified antiserum feedstock, and the best of 
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these was selected for all further work. Subsequently conditions for optimal use of the chosen MEP-
linked magnetic adsorbent for immunoglobulin capture and purification were systematically 
established, and the adsorbent holding capacity of a small high-gradient magnetic filter unit 
positioned in bore of a mini-pilot scale ‘ON–OFF’ permanent HGMS unit was determined. Efficient 
use of MEP-linked magnetic adsorbents was then demonstrated at sevenfold increased scale in an 
HGMF process to recover immunoglobulin in substantially pure form and high yield from a ‘dirty’ i.e. 
unclarified, antiserum feed. The study concludes with a discussion of some of the measures required 
to maximise HGMF’s untapped potential as a direct capture technology for fast recovery of target 
antibodies and other proteins expressed at high titre in complex unclarified bioprocess liquors.  
 
EXPERIMENTAL  
Materials 
The 430 stainless steel wire matrix (KnitMesh type 9029) and the rabbit anti-human transferrin 
antiserum employed in this work were received as gifts from KnitMesh Ltd (South Croydon, Surrey, 
UK) and Dako Agilent Pathology Solutions (Glostrup, Denmark), respectively. Iron (II) chloride 
hexahydrate, dimethyl sulphoxide (99.5%) and Silica gel 60 F254 plates for thin-layer chromatography 
(TLC) were supplied by Merck (Darmstadt, Germany), while iron (III) tetrahydrate was purchased 
from Mallinckrodt Baker B.V. (Deventer, the Netherlands). The following materials were purchased 
from the Sigma-Aldrich (St. Louis, MI, USA): thiolacetic acid; 4-vinylpyridine; diethyl ether; sodium 
bicarbonate; sodium chloride; anhydrous magnesium sulphate; hydrochloric acid; isopropanol; 
deuterium oxide; methanol; glacial acetic acid; 3-aminopropyltriethoxysilane; glycerol; 
glutaraldehyde (50 %, photographic grade); sodium borohydride; sodium carbonate; epichlorohydrin 
(ECH); allyl bromide (AB); allyl glycidyl ether (AGE); divinyl sulphone (DVS); N-
bromosuccinimide (NBS); Trizma® base (≥99%); ammonium sulphate; citric acid monohydrate; 
sodium citrate dehydrate; anhydrous sodium acetate; and, protein standard (bovine serum albumin). 
All the reagents for the rabbit immunoglobulin immunoturbidimetric assay (i.e.: dilution buffer – 
S2005; reaction buffer – S2008; goat anti-rabbit immunoglobulins ‘GoaRbIg’ – Z0421; dilution 
buffer for GoaRbIg – TO 0463; and Ig standard – X0903 concentrate), were obtained from Dako 
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Agilent Pathology Solutions (Glostrup, Denmark). Bicinchoninic acid (BCA) protein assay kits were 
supplied by Pierce (Rockford, IL, USA), while pre-cast Invitrogen branded SDS-PAGE gels, Novex 
Colloidal Blue protein staining kit, molecular weight markers (myosin – 200 kDa, β–galactosidase – 
116.3 kDa, phosphorylase b – 97.5 kDa, bovine serum albumin – 66.2 kDa; glutamate dehydrogenase 
– 55.4 kDa, ovalbumin – 45 kDa, carbonic anhydrase – 31 kDa, trypsin inhibitor – 21.5 kDa, 
lysozyme – 14.4 kDa; aprotinin – 6.5 kDa), sample and running buffers were acquired from 
Thermofisher (Waltham, MA, USA). All other materials not identified above were acquired from 
Sigma-Aldrich and Merck. 
 
Synthesis of 4-mercaptoethylpyridine hydrochloride 
The hydrophobic-charge induction ligand used in this work, 4-mercaptoethylpyridine HCl, was 
prepared using a modified version of the method described by Burton.28 Under stirring 125 mL of 4-
vinylpyridine (95%) was pre-chilled to –30°C in a methanol/dry ice bath. Thiolacetic acid (85 mL) 
was then added at a rate of 0.5 mL per minute and the temperature was maintained at ~23°C by 
immersing the reaction vessel in a water bath held at 20 ± 2°C. After 15 h of stirring at room 
temperature, the product was mixed with 200 mL of diethyl ether and extracted four times with 160 
mL portions of saturated sodium bicarbonate solution. The separated ether layer was subsequently 
washed twice with 150 mL portions of saturated sodium chloride, treated with activated charcoal to 
reduce colour, dried over anhydrous magnesium sulphate, then filtered and evaporated under vacuum 
(bath temperature ~30°C). The resulting oil was stirred with 400 mL of 6 M HCl. After 4 h the acid 
layer was reduced under vacuum, the dried residue was re-slurried with 150 mL of isopropanol and 
recrystallized overnight at –18°C, before filtering and finally drying under vacuum to yield a dark 
creamy solid. This was then re-dissolved in another 400 mL portion of 6 M HCl and stirred at room 
temperature. The reaction was monitored by TLC and stopped after 40 h. Subsequent concentration, 
re-crystallisation from 150 mL of isopropanol, filtration and drying gave a creamy white solid (81 g, 
40 % yield) identified as the desired compound: 1H NMR (D2O, 300 MHz) δ 2.89 (t, 2 H, CH2-SH, J 
7.1 Hz), 3.18 (t, 2 H, Pyr-CH2, J 7.1 Hz), 7.89 (d, 2 H, H-2, H-2’, Pyr, J 6.6 Hz), 8.59 (d, 2 H, H-3, H-
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3’, Pyr, J 6.8 Hz); 13C NMR (D2O, 300 MHz) δ 23.27 (CH2-SH), 39.22 (Pyr-CH2), 127.85 (Pyr, C-3, 
C-3’), 140.64 (Pyr, C-2, C-2’), 162.44 (Pyr, C-4).  
 
Support handling 
A strong (>0.5 T) NdFeB permanent magnet block (Danfysik A/S, Jyllinge, Denmark) was used to 
separate magnetic particles from liquid phases during preparation of the magnetic adsorbents (10 g 
scale). In small-scale functionalisation steps and in batch binding studies, magnetic adsorbents were 
recovered from suspension with the aid of ~0.15 T side-pull NdFeB racks (chemagic Stands 50k Type 
A and 2×12, PerkinElmer chemagen Technolgie GmbH, Baesweiler, Germany).  
 
Manufacture of 4-mercaptoethylpyridine-linked superparamagnetic adsorbents 
The construction of MEP-linked magnetic adsorbents employed in this study is shown schematically 
in Fig. 1 and described below.  
 
Base materials 
Detailed steps for the preparation of polyglutaraldehyde (PG) coated magnetic starting materials have 
been presented in full elsewhere20,29,30 and are only briefly summarised here. Ten grams of cation 
deficient superparamagnetic iron oxide crystals were prepared by chemical precipitation involving 
aqueous mixed iron chloride salts and a strong base. These crystals were subsequently formed into 
submicron-sized particles by performing silanization with 3-aminopropyltriethoxysilane (3-APTES) 
in a high-shear environment, and then stabilising the aminosilane coat by curing the magnetic 
particles in glycerol at high temperature under nitrogen.20 The resulting amine-terminated 
superparamagnetic particles were then coated with a layer of polyglutaraldehyde by stirring with 2% 
(v/v) glutaraldehyde at pH 11 in a pH stat vessel29 to yield irregular particles (Dv50 = 0.80 μm, Dv20–80 
of 0.65–1.12 μm) with high saturation magnetization (MS = 53.3 ± 2.1 Am2 kg-1) and low remanence 
(MR = 0.28 ± 0.09 Am2 kg-1). 
 
Activation 
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Next, PG-coated supports were variously activated (as described previously by Heebøll-Nielsen et 
al.23,30) before coupling with 4-MEP to produce the four different MEP-linked supports designated 
Types I – IV (Fig. 1). The manufacture of type I supports involved prior activation of PG coated 
particles (25 g L-1) for 6 h at 21°C with 5% (v/v) epichlorohydrin (ECH) in 0.5 M NaOH and 19 mM 
NaBH4. The preparation of type II and III MEP-linked supports involved activation with allyl bromide 
(AB) and allyl glycidyl ether (AGE) respectively, using a procedure adapted from Burton and 
Harding31. PG-coated supports (33 g L-1) suspended in 0.15 M NaOH and 36 mM NaBH4 in 50% 
(v/v) DMSO were mixed with AB (type II) or AGE (type III) to a final concentration of 50% (v/v), 
incubated for 48 h at room temperature and then washed extensively with water. The resulting 
allylated particles (20 g L-1) were reacted (1 h, 21°C) with 0.14 M N-bromosuccinimide (NBS) 
introducing reactive bromohydrin moieties. Finally, the creation of type IV magnetic adsorbents 
involved DVS-activation. In this procedure, DVS was added at regular intervals over 600 s to PG-
coated support particles (25 g L-1) in 0.5 M Na2CO3 containing 18 mM NaBH4 to a final amount of 8 
mL g-1 particles. The reaction was subsequently allowed to proceed for 1 h at room temperature.  
 
Coupling 
Prior to coupling, all activated supports were washed extensively with water by repeated cycles of 
resuspension, mixing and magnetic separation. The pH of a 0.7 M solution of 4-
mercaptoethylpyridine HCl in water was adjusted to 11.5 with saturated NaOH and subsequently 
diluted to 55 mM in 0.5 M Na2CO3 containing 28 mM NaBH4. Portions of this solution were then 
mixed with ~1 g quantities of activated supports (final support concentration of 6 g L-1) in sealed glass 
Duran® bottles for 48 h on a vibrating shaker at 21°C. The finished supports were magnetically 
retrieved from suspension and washed copiously with 0.5 M NaCl and then water before finally 
storing at 4°C in 20 mM sodium phosphate, 1 M NaCl, pH 6.8 until required. The presence of 4-MEP 
in the final adsorbent preparations was assessed by FTIR.  
 
Feedstock 
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The rabbit antiserum used in this work is a highly complex feedstock containing unusually high levels 
of immunoglobulin (Ig).5.6 For all small scale binding studies and determination of adsorbent loading 
capacity to use in HGMF, crude rabbit antiserum pools from ‘Danish Whites’ were first filtered free 
of particulate matter by passage through a Nalgene disposable dead end membrane to yield clarified 
undiluted sera hereafter designated ‘100% serum strength (the mean Ig and total protein 
concentrations in serum were determined as 25 ± 1.3 g L-1 and 93 ± 2 g L-1 respectively and the 
electrical conductivity at 20°C was 10.8 mS cm-1). This feedstock was used in variously diluted forms 
yielding serum strengths ranging from 0.04 to 22.5% (v/v). For the recovery of Ig by HGMF, the 
crude (unclarified) antiserum was simply diluted tenfold. 
 
Batch binding and elution studies 
Small scale batch binding and elution tests were conducted in 2 mL screw-capped vials (Sarstedt, 
Nümbrecht, Germany) at room temperature. Supports (1.8 – 45 mg) were magnetically recovered 
from storage buffer, resuspended and equilibrated in a defined volume of appropriate binding buffer 
by two cycles of resuspension and magnetic separation, before portioning into vials. Some samples 
were mixed with 1.5 mL aliquots of diluted antiserum for various times at 21°C on an IKA VXR-S17 
vibrating shaker platform (IKA Labortechnik, Staufen, Germany), whereas others were sacrificed for 
dry weight measurements in order to determine the exact amounts of support used in each test. After 
binding, supports were retrieved on a magnetic rack, washed once briefly (30 s) with binding buffer, 
before adding elution buffer (0.1 – 1 M sodium acetate) and incubating for 600 s on a vibrating 
shaker. In most cases 2 sequential elution cycles were performed.  
The initial selection of buffers for equilibration/washing and elution was informed by previous 
work on the chromatography of human32 and especially rabbit5,6 polyclonal antibodies on MEP 
HyperCel.  
In preliminary screening of the various MEP-linked support types (I – IV), supports (9 – 12 mg) 
were equilibrated with 50 mM Tris-HCl pH 8 and then incubated with 1.5 mL of 20% (v/v) antiserum 
for 0.5 h. After magnetic separation the supports were washed with binding buffer, before finally 
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incubating protein laden adsorbents for 0.5 h with 1.5 mL of elution buffer (50 mM sodium acetate, 
pH 4).  
All subsequent characterisation of binding, washing and elution operations were conducted with 
type III supports. Binding optimization was performed at 1.5 mL scale (using 10% v/v antiserum 
feedstocks and 8.5 mg mL-1 of supports) by systematically varying the contact time (20 – 900 s; 50 
mM Tris-HCl pH 8), pH (employing 50 mM sodium citrate pH 6 and 50 Tris-HCl pH 7 – 9 buffer) 
and doping of binding buffer (50 mM Tris-HCl pH 8) and diluted antiserum with various 
concentrations (0 – 150 mM) of ammonium sulphate or sodium chloride. After identifying the ‘best’ 
conditions for Ig binding, the adsorption performance of the type III MEP-linked support was 
characterised further in two sets of experiments in which various dilutions (4.5 to 2,500 fold) of 
antiserum were contacted with a fixed concentration of supports (4.6 mg mL-1), and 10.2% (v/v) 
antiserum was mixed with support at final concentrations of 1.2 – 30 mg mL-1. The key variable 
examined in optimization of washing immediately post binding and prior to elution was the support 
concentration, whereas for elution, in addition to varying support concentration, different strengths 
(0.05 – 1 M) of sodium acetate and citrate buffers and fine tuning of elution pH (between 3.5 and 4.5) 
were explored. 
Liquid-phase samples from all of the above tests (antiserum feedstock, unbound, wash and 
elution fractions) were retained for determination of residual Ig and total protein contents, and protein 
composition. The amounts of bound Ig and total protein were computed from the difference in liquid 
phase concentration before and after binding, and in some cases adsorption data were fitted to the 
Langmuir model33 (Equation (1)):  
*
** max CK
CQQ
d +
=          (1) 
where Q* and C* respectively represent the equilibrium concentrations of adsorbed and liquid-phases 
binding species, Qmax is the maximum protein binding capacity of the support, and Kd is the 
dissociation constant. Data was fitted to the model using the χ2 minimization procedure of OriginPro 
2017 software (OriginLab Corporation, Northampton, MA, USA).  
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High-Gradient Magnetic Fishing (HGMF) 
Equipment set-up and operation 
A schematic illustration of the laboratory scale HGMF rig employed in this work is shown in Figure 
2; the operation of which has been described in detail by Meyer et al.25. At its core is a 70 kg mini-
pilot scale cyclically operated ‘ON–OFF’ permanent magnet based high-gradient magnetic separator 
(HGF-10, Steinert Elektromagnetbau GmbH, Köln, Germany) with an adjustable air-gap between the 
poles of 1.5 – 2.5 cm. In this study, the gap was set to 1.5 cm and the measured magnetic flux 
densities in the ‘ON’ and ‘OFF’ positions were respectively 0.56 and 0.03 T. A small magnetic filter 
was constructed by inserting a tightly-rolled mat of woven 430 stainless steel mesh (fibre thickness 
~110 µm) into a 4.4 mL plastic canister (56 mm long × 10 mm i.d) so that it occupied 11% of the 
working volume (i.e. voidage = 0.89, void volume = 3.9 mL). The resulting magnetic filter was then 
positioned vertically between the pole shoes (area = 100 mm × 80 mm). The HGMF set up comprised: 
(i) a stirred batch adsorption reactor; (ii) the aforementioned magnet and magnetic filter canister; two 
peristaltic pumps (Masterflex L/S Easy-Load model 7518-00, Cole Parmer Instruments Co., Vernon 
Hills, IL, USA); and (iv) SuperFrac fraction collector fitted with high flow adaptors (GE Healthcare, 
Uppsala, Sweden). The flow paths for particle loading, washing, protein elution, and particle recovery 
were controlled with a set of three-way solenoid switching valves (Bürkert Werke GmbH Fluid 
Control Systems, Ingelfingen, Germany). With the field switched ‘ON’, the adsorbent 
particle/feedstock suspension was pumped to the magnetic filter through values 1–3 via pump 1. 
Washing and elution operations were conducted with the aid of a recycle loop (11.6 mL). After filling 
the loop via valves 4 and 5, the canister–loop circuit (available volume = 15.5 mL) was closed by 
switching valves 2 and 3. The field was switched ‘OFF’ and the liquid contained within the closed 
loop was driven at high speed via pump 2 to release particles from the magnetic filter wires. 
Subsequently the field was switched back ‘ON’ to recapture the magnetic adsorbent particles, and 
after turning valve 3, washed off or eluted materials were sent to the fraction collector. Finally, 
support particles were recovered by switching the field ‘OFF’ and pumping out of the system via 
pump 1. The HGF-10 magnet, pumps and valves were all controlled by National Instruments™ 
LabVIEW software (Austin, TX, USA).  
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Determination of filter capacity 
Prior to carrying out HGMF recovery of Ig from unclarified rabbit antiserum, the loading capacity of 
the HGMF filter for type III MEP-linked magnetic adsorbents was examined in a breakthrough study 
employing clarified 10% (v/v) antiserum containing support particles at a concentration of 30 mg mL-
1. With the field switched ‘ON’ the suspension was loaded into the magnetised filter at a linear flow 
rate of 24 m h-1. Particle breakthrough in the filter effluent was monitored by gravimetric 
measurement of the particle mass in collected samples.  
 
Recovery of immunoglobulins from unclarified rabbit antiserum by HGMF 
Type III magnetic MEP-linked adsorbents (previously equilibrated in 50 mM Tris-HCl, pH 8) were 
resuspended in crude unclarified rabbit antiserum (diluted in the same buffer) to give final particle and 
antiserum concentrations of 31.7 mg mL-1 and 10% (v/v) respectively, and thereafter mixed at room 
temperature with an overhead stirrer for 600 s. Subsequently, with the magnet switched ‘ON’, the 
particle/antiserum suspension was pumped upward through the magnetic filter at a linear flow rate of 
24 m h-1. Pumping was stopped before breakthrough was expected, i.e. after 11.5 mL of suspension 
containing 365 mg particles had been loaded into the magnetised filter. The recycle loop (11.6 mL) 
was then filled with washing buffer (50 mM Tris-HCl, pH 8) and after turning the field ‘OFF’, the 
suspension was pumped around the recycle loop upwards with respect the magnetic filter at a velocity 
of 92 m h-1 for 60 s, to wash out entrained and/or loosely adsorbed materials. The particles were 
subsequently recaptured by switching the field back ‘ON’, the flow rate was lowered to 24 m h-1 and 
the washings were pumped out of the rig to the fraction collector. Bound Ig and protein was desorbed 
from the retained MEP-linked adsorbent particles in 600 s elution cycles in exactly the manner just 
described for washing, i.e. by filling the recycle loop with elution buffer (0.5 M sodium acetate, pH 
4), and rapidly circulating the particles around the closed system loop. The volumes of all collected 
fractions were accurately measured and all fractions were analysed for immunoglobulin and total 
protein contents, and composition by SDS-PAGE. 
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Analytical techniques 
Thin-layer chromatography was performed on Merck Silica gel 60 F254 plates and spots were 
visualised under ultra-violet light. 1H and 13C NMR spectra were recorded at 500 and 125.7 MHz, 
respectively, on a Varian Inova 500 spectrometer.  
For qualitative FT-IR analysis of solid supports, 2 mg samples previously dried in a desiccator 
were mixed with 298 mg potassium bromide, ground down to a fine powder and hydraulically pressed 
(15 tonnes) into tablet form. Each tablet was subjected to 64 scans (averaged at a resolution of 2 cm−1) 
in a Nicolet 380 FT-IR (Thermo FisherScientific, Waltham, MA, USA) in direct beam mode.  
Magnetic particle content was determined using a dry weight method based on that described by 
Hubbuch and Thomas.20 Bulk magnetic properties were investigated at ambient temperature in a 
MicroMag™ 2900 Alternating Gradient Magnetometer (PMC, Princeton, NJ, USA) and particle size 
analysis was performed with a Mastersizer2000 particle size analyser (Malvern Instruments Ltd, 
Malvern UK). 
The concentration of antibodies in bulk phase samples was determined using a robust high 
throughput immunoturbidimetric assay advanced by Bak and coworkers34. The method is based on the 
scattering of light caused by the formation of different sizes of immune complexes by different ratios 
of antibody to antigen, was specifically developed for in-process determination of polyclonal antibody 
concentration in crude samples, and has been shown to be insensitive to all of the 
equilibration/binding/wash and elution buffer combinations employed in this work. The original 96-
well plate procedure was adapted so that it could be performed automatically in a spectrometric robot 
system (Cobas Mira Plus Random Access Analyser, Roche Diagnostic Systems, Rotkreutz, 
Switzerland) as follows: Samples (35 µL) were mixed with 126 µL of reaction buffer and incubated at 
37ºC. After 300 s, the absorbance was recorded at 340 nm and 84 µL of twofold diluted GoaRbIg was 
added. After 300 s incubation at 35ºC, the absorbance was again recorded at 340 nm. Standards of 
purified immunoglobulins from non-immunised rabbits, prepared in dilution buffer to a final 
concentration ranging from 6.6 to 500 μg mL-1, were treated in exactly the same way as the samples.  
The total protein contents of liquid phase samples were determined by the BCA protein assay 
(Pierce Rockford, IL, USA) adapted for use in the Cobas Mira Analyser. All results are expressed in 
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mg bovine serum albumin (BSA) equivalents. Corrections for variation in Ig content in samples were 
not applied. In the assay the %1.0562 nmA rabbit IgG:
%1.0
562 nmA  BSA ratio = 1.12; thus calculated figures for Ig 
purity, purification and yield factors, in this work, are underestimated.  
Protein composition was analysed by reducing SDS-PAGE35 in NuPAGE® Novex Bis-Tris (4–
12%) gels. Images of gels were captured using a GelDoc2000 system (Bio-Rad Laboratories, 
Hercules, CA, USA) and the relative densities of stained bands in destained gels were analysed using 
ImageJ software, downloaded from http://rsb.infonih.gov.ij/.  
The RSA contents in eluates are expressed as percentages of the Ig signal by dividing the RSA 
band intensity in each lane by the combined Ig heavy and light chain band intensities, and then 
multiplying by 100.  
 
RESULTS AND DISCUSSION 
Magnetic support design 
Gu and coworkers36 recently demonstrated effective use of magnetic agarose based adsorbents 
derivatised with the hydrophobic-charge induction ligand, 5-aminobenzimidazole, for antibody 
capture from a dilute mimetic serum (IgG + BSA), mimetic serum ‘spiked’ with yeast cells, and CHO 
culture supernatant. The much more complex, concentrated and fouling antiserum feeds used in this 
work dictated choice of a less ‘challenged’ adsorbent design. Much previous work confirms that sub-
micron sized non-porous magnetic adsorbents fashioned from the PG coated superparamagnetic base 
particle described by Hubbuch and Thomas20 are well suited for operation in unclarified and heavily 
fouling bioprocess liquors.18,22–25,30 It is rarely appreciated that non-porous supports are less prone to 
fouling and easier to clean once fouled, than their porous counterparts,37,38 and are therefore inherently 
more useful for product capture and purification from fouling liquors.15 For porous supports, intra-
particle pore fouling is an especially serious issue. Foulants ingressing into and trapped within pores 
are more difficult to dislodge that those adhering to the external surface; this is largely because 
internal pores are effectively isolated from the effects of external fluid shear cf. the external 
surface.37,38  
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Screening of MEP-linked adsorbents prepared via different activation routes 
Four different activation chemistries were employed on PG coated magnetic particles prior to 
coupling MEP (Fig. 1). FTIR analysis confirmed successful installation of 4-MEP in all cases. The 
spectra of finished adsorbents contained absorbance peaks at ~804 cm-1 and ~1599 cm-1 
corresponding to the thioether bond (-C-S-C-) and imine respectively, whereas those of controls (i.e. 
activated supports subjected in parallel to the same coupling conditions, but without of 4-
mercaptoethylpyridine) showed no such peaks. Table 1 shows the results of initial matrix scouting 
performed with the various MEP-linked supports (I – IV) at a concentration of 7 mg mL-1 in 20% 
(v/v) clarified rabbit antiserum representing an effective challenge of 28.6 mL of undiluted ‘100%’ 
serum per g support. Under these conditions, between 5.6 and 25.4% of the available Ig and 9.1 to 
19.8% of the total soluble protein was removed from antiserum. Only two of the four supports bound 
Ig selectively over total protein, i.e. types I and III. Though the highest Ig binding (181 mg g-1) was 
demonstrated by the type I support prepared by ECH activation route with purification, the type III 
support (Ig binding capacity = 170 mg g-1), produced via two-step AGE activation and bromination 
procedure, demonstrated substantially greater Ig binding selectivity. The purity on adsorption was 
>56% (cf. 34.4% for type I) reflecting a purification adsorption (PFads) of 2.1 (cf. <1.3 for type I). 
Surprisingly, type II and IV supports displayed greater preference for the binding of non-Ig proteins 
reflected by lower purity of Ig in the adsorbed state, i.e. 11.5% and 18.5% for types II and IV 
respectively cf. that of the initial antiserum (26.9%). In all cases, the wash step, conducted 
immediately post binding, desorbed large amounts of entrained and weakly adsorbed protein, such 
that significant enhancements in adsorbed Ig purity were achieved prior to elution. For example, in the 
best case (type III supports) 46% of the adsorbed total protein was desorbed at the expense of a 14% 
loss in bound Ig such that the purity rose to 89%. In the subsequent pH elution step, Ig was 
preferentially eluted over other adsorbed proteins from all supports (Table 1). A palpable trend, 
supported by electrophoretic analysis (Fig. 3), is that the greater the selectivity displayed by the 
support (type III > I > IV >II) during the binding step, the higher the Ig purity of the final eluate (95% 
for type III, 92% for type I, 83% for type IV and 64% for type II). All eluates contained rabbit serum 
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albumin (RSA), the main impurity in serum, but the levels of RSA contamination varied markedly. 
Whereas strong RSA bands are evident in lanes corresponding to eluates from type IV and II supports, 
they are barely discernible in the eluates from the type I and III adsorbents. With the aid of Image J 
analysis, the signal intensities for RSA expressed as percentages of the combined Ig band intensities 
in each lane were determined as 2, 4, 13 and 41% for the eluates from support types III, I, IV and II 
respectively. The type III adsorbent prepared by the AGE activation route was selected for use in all 
further studies in view of its superior overall performance. Nearly 14% of the Ig present in the 
antiserum was recovered with a purity of 95% representing a purification of >3.5 fold.  
Though neither the extent of activation nor MEP ligand density were measured in this work, the 
differences in Ig binding and purification performance noted here (Table 1 & Fig. 3) for the various 
MEP-linked magnetic adsorbents likely stem from a complex interplay of spacer chemistry (Fig. 1) 
and immobilised ligand density. Boschetti39 stressed: (i) the potential benefits of the including a 
sulphur atom in the spacer (applicable in the case of the type IV support prepared via DVS activation, 
see Fig. 1); (ii) the importance of employing sufficiently hydrophobic spacer arms; and crucially (iii) 
that IgG adsorption is strongly dependent on the density of hydrophobic MEP ligands anchored to the 
support’s surface. Adsorption can only occur when a certain critical hydrophobicity40 is reached (in 
the case of MEP HyperCel Boschetti39 states this is >40 mmol mL-1); beyond this point binding 
capacity increases until saturation. The superior performance of the type III adsorbent over other types 
in this work likely reflects it represents the best ‘ligand density/spacer hydrophobicity’ combination.  
 
Optimisation of binding conditions 
Figure 4 shows the results of systematic experiments aimed at identifying effective binding conditions 
for selective recovery of immunoglobulins from clarified 10% (w/w) rabbit antiserum using type III 
non-porous magnetic MEP-linked adsorbents at support concentration of 8.5 mg mL-1 (challenge = 
11.8 mL equivalents of 100% serum per g support).  
 
Kinetics 
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The kinetics of Ig and protein binding are presented in Fig. 4a. As has been noted previously with 
other adsorbents fabricated from the same submicron sized and essentially non-porous magnetic base 
matrix, binding equilibrium is attained very rapidly;22,25,26,30,41,42 in the present case by the first time 
point, i.e. 45 s, which represents the minimum time required for handling samples on the magnetic 
rack. No difference in binding kinetics for Ig and total protein was observed in the experiment, thus 
the adsorbed Ig purity remained constant averaging 55.34 ± 2.38% over 10 time points between 45 
and 900 s. For purely practical reasons, a binding time of 600 s was adopted in all subsequent work.  
 
pH 
Varying the pH of the binding buffer used for support equilibration and dilution of the antiserum 
exerted a strong impact on both the amount and selectivity of Ig binding by the adsorbent (Fig. 4b). 
Maximum Ig binding (46.7% of that presented) and selectivity of adsorption (PFads = 2.07 – 2.14 
corresponding to a purity on adsorption of 57.5%) were obtained at a pH of 8, and substantial 
retention of binding selectivity was maintained between pH 7 and 9. However, shifting to lower pH 
values seriously compromised both the level and selectivity of Ig binding. For example, at pH 6 <16% 
of the available Ig was adsorbed and all binding selectivity was lost (calculated Ig purity of 26.6% is 
less than that of the initial antiserum). The pH dependence of rabbit Ig adsorption on type III MEP- 
magnetic adsorbents observed here accords with earlier studies conducted with human polyclonal IgG 
and MEP HyperCel, and is consistent with the 4-MEP ligand’s pKa of 4.8 and the pH-dependent 
adsorption-desorption mechanism described by Burton and Harding31 and corroborated by Boschetti 
and colleagues32,39, i.e. hydrophobic interaction under near physiological conditions in the absence of 
a lyotropic salt, and desorption via pH induced electrostatic charge repulsion.  
 
Influence of salt concentration  
Guerrier et al.32 previously reported that polyclonal human IgG binding to MEP HyperCel is salt-
independent up to an electrical conductivity of 100 mS cm-1 (the authors employed 25 mM sodium 
phosphate pH 7 variously supplemented with up to 1 M NaCl). Boschetti39 later confirmed no 
difference in the binding of human polyclonal antibodies to MEP HyperCel in the absence and 
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presence of added sodium chloride, but that the addition of ammonium sulphate conveyed higher 
binding capacities consistent with thiophilic adsorption which is enhanced by the presence of 
lyotropic salts.43 Different behaviour is exhibited by the type III MEP-linked adsorbent and rabbit 
antibodies employed here. Antiserum was diluted tenfold with 50 mM Tris-HCl pH 8 buffers 
supplemented with ammonium sulphate (lyotropic) or sodium chloride (chaotropic) at various 
concentrations up to 150 mM and contacted with adsorbents previously equilibrated in the same 
buffer. Figure 4c shows ammonium sulphate and sodium chloride data series – for % bound Ig and 
total protein and % purity in the adsorbed state vs. conductivity – collapsing along common curves, 
and that increasing conductivity compromises both the level and selectivity of Ig adsorption 
significantly. For example, addition of 0.15 M ammonium sulphate to the clarified rabbit antiserum 
feedstock (which raised the electrical conductivity at 20°C from 5.6 to 31.5 mS cm-1) led to >40% 
reduction in binding coupled with a drop in adsorbed purity from 57.5 to <45%. The salt dependent 
binding observed here for rabbit Ig from antiserum on MEP may in part reflect rabbit IgG’s (the 
dominant species in the feedstock) observed tendency to dimerise as salt concentration is 
increased.44,45 A reduction in Ig binding with increasing levels of salt induced dimer is consistent with 
the observation of reduced binding capacities for larger Ig isotypes, e.g. IgA.39 However, in a recent 
study with pure hIgG and MEP HyperCel, Yuan and coworkers46 noted similar binding trends at low 
concentrations of NaCl and (NH4)2SO4, i.e. steady reductions in binding capacity with increasing 
concentration, reaching minima at 250 mM of both salts; followed by increased binding with further 
addition of salt. Yuan et al.46 examined this complex behaviour using isothermal titration calorimetry, 
revealing that the addition of low levels of salt (0 – 0.25 M) weakened hydrophobic interactions 
(causing entropy change) and strengthened van der Waals, H-bonding and ionic interactions which 
lead to negative enthalpy change, whereas higher concentrations (0.25 – 0.75 M) resulted in increased 
hydrophobic and diminished electrostatic interactions.  
 
Characterization of binding performance of type III MEP-linked adsorbent for use in HGMF 
Antiserum/support ratio 
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The most important parameter affecting the performance of any HGMF process is the magnetic 
adsorbent’s selectivity for the target product in the feedstock from which it is to be recovered. 
Effective conditions for the capture of rabbit polyclonal Ig from tenfold diluted antiserum established, 
(i.e. adsorption time of 600 s, support equilibration and feedstock dilution with 50 mM Tris-HCl pH 
8), it was subsequently necessary to further probe the equilibrium state developed within the 
adsorption vessel by systematically mapping the impact of antiserum/support ratio (specifically mL 
equivalents of 100% serum per g of support) on the immunoglobulin yield and purity achieved in the 
adsorption step. This was done in two ways. In the first cycle of experiments, a fixed concentration of 
type III MEP-linked magnetic adsorbents (4.6 mg per mL of feedstock) was contacted with 2,500 – 
~4.5 fold diluted rabbit antiserum (Fig. 5a), representing antiserum/support ratios ranging from 0.08 – 
~49 mL equivalents of 100% antiserum per g support. In the second experimental series (Fig. 5b), 
fixed volumes of 10.2% (v/v) antiserum were mixed with various concentrations of the same support 
(final concentrations of 1.2 – 30 mg per mL of feedstock) to give a narrower, but more densely 
populated window of ‘antiserum/support’ challenges (3.4 to ~85 mL equiv. 100% antiserum per g 
support). The influence of antiserum/support ratio on the binding performance of type III MEP-linked 
adsorbents (transposed from the data in Figs 5a and 5b) is illustrated in Figure 6. Essentially complete 
Ig adsorption required antiserum/support ratios <1 mL equiv. 100% antiserum per of support (Fig. 
6a). However, at such low antiserum/support challenges, the operational Ig binding capacity is very 
low (<30 mg g-1) and co-adsorption of non-Ig proteins unacceptably high (>60% of the total protein 
supplied) such that the purity of the adsorbed Ig is 40% or less, corresponding to purification factors 
on adsorption, PFads, of <1.5. The Ig binding capacity of the type III adsorbent rose strongly as the 
antiserum/support ratio was increased, reaching 140 and 200 mg g-1 at values of 10 and 50 mL equiv. 
100% antiserum per g support respectively, albeit at the expense of marked losses in adsorbed Ig yield 
(Fig. 6a). The total protein binding capacity of the adsorbent increased in similar manner, rising from 
<70 mg g-1 at 1 mL equiv. 100% antiserum per g support to 240 mg g-1 at 10 mL equiv. 100% 
antiserum and on past 350 mg g-1 at 50 mL equiv. 100% antiserum per g support, a value indicative 
from past experience with adsorbents fashioned out of the polyglutaraldehyde-coated magnetic base 
particle employed here of multi-layer binding.23  
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The degree of purification achieved on adsorption (PFads) was observed to rise as 
antiserum/support ratio was raised, reaching a maximum value of >2 at 20 mL equiv. 100% antiserum 
per g support and thereafter declining slightly with further increase in antiserum/support ratio in 
keeping with the aforementioned transition from mono- to multi- layer protein binding.  
Identifying the correct amount of magnetic adsorbent to treat a given volume and strength of 
feedstock is an especially important design consideration for an HGMF process.18,19 A favourable 
operation point may be defined mathematically by the yield factor, i.e. the product of the purification 
factor and fractional yield of the target species.18,25 In the present case the maximum yield factor on 
adsorption, YFads, occurs at an antiserum/support challenge of ~3 mL equiv. 100% antiserum per g 
support (Fig. 6b). Practically, this corresponds to treatment of a 10% (v/v) antiserum feedstock with 
the type III support at a final particle concentration of 25 – 30 mg mL-1. Under these conditions, >90% 
of the Ig present in the antiserum is adsorbed in a 1.9 fold purified state (Purityads = 53%) at a working 
capacity of >80 mg g-1.  
Bak5 has previously reported that the adsorption of rabbit antibodies to MEP HyperCel is weaker 
than that of human IgG and that dynamic binding capacities were roughly half those of human IgG. 
Despite this, and the abundance of non-Ig proteins in rabbit antiserum esp. RSA, measurements of 
free Ig content in 4.5 to 833 fold diluted antiserum feedstocks remaining after 0.25 h of contact 
confirmed strong (Kd <0.1 mg mL-1 ≈ 0.5 μM) high capacity (Qmax = 214 mg g-1) adsorption from the 
feedstock (Fig. 7a). Measurements of free total protein on the other hand produced a differently 
shaped binding curve, namely initially favourable rising towards a plateau around 200 mg g-1, but then 
curving strongly upwards (indicative of multi-layer binding) as the concentration of antiserum 
supplied is increased.23 The non-selective binding nature of the MEP ligand, well documented in the 
case for MEP HyperCel6,39, is also noted for the magnetic MEP-linked adsorbents employed herein.  
Despite favourable adsorption of the target Ig, substantial non-specific protein binding is 
observed at all antiserum/support challenges (Fig. 6). That this binding is weak is highlighted by the 
observation in Fig. 7b that a single rapid 30 s washing step employing the binding/dilution buffer 
dislodges much of the adsorbed protein resulting in substantial increases in purity of adsorbed Ig prior 
to elution albeit at the expense of small drops in Ig yield (see later, Tables 2 & 3). Beyond Q*Total Protein 
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~100 mg mL-1, the amount of adsorbed protein removed by washing rises strongly as Q*Total Protein is 
raised, reaching ~58% at the highest loading (i.e. 215 of the 373 mg adsorbed per gram).  
Attempts to reduce the level of non-specific binding by adding sodium caprylate (an albumin-
selective moiety) to the antiserum feedstock prior to binding and/or the use of sodium caprylate wash 
post binding39,47 were not undertaken to avoid adding ‘another layer of complexity to the purification 
process’.12 Washing with distilled water prior to elution has been reported as a means of selectively 
eluting non-specifically adsorbed albumin from MEP HyperCel,32,39 but was avoided in this work in 
view of Bak’s5 observation that the water wash desorbs rabbit immunoglobulins more readily from 
MEP HyperCel columns than bound RSA. 
 
Adsorbent collection by HGMS 
Prior to selecting conditions for elution in HGMF, it was necessary to establish the likely particle 
concentration under which washing and elution could be permitted by the present HGMF system. This 
involved defining the capacity of the magnetic filter for type III adsorbent particles from 10% (v/v) 
antiserum under processing conditions (support concentration = 30 mg mL-1, B = 0.56 T, v = 24 m h-1) 
and subsequently calculating the likely adsorbent concentration within the magnetic filter canister and 
associated recycle loop during washing and elution. Five percent particle breakthrough occurred after 
the application of 430 mg of type III support had into the magnetized filter, corresponding to a 
particle holding capacity of 97.7 g L-1 based on the total volume of the filter. The combined volume of 
the recycle loop (11.6 mL) and filter cartridge (4.4 mL) minus the 430 stainless steel matrix (0.5 mL) 
in which desorption occurs, is 15.5 mL. Thus, assuming the support is applied at 75 – 90% of the 
magnetic filter’s 5% breakthrough capacity the support concentration during desorption within the 
HGMF apparatus would be 20 – 25 mg mL-1. Accordingly, a target concentration of ~20 mg mL-1 of 
protein loaded adsorbents was selected for optimisation of elution conditions. 
 
Optimisation of elution conditions for HGMF 
In preliminary tests, varying the pH of the 50 mM acetate buffer, by ± 0.5 units from the initial value 
of 4 employed in screening the different MEP-linked supports, gave no improvement in desorption 
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efficiency from washed protein-laden supports, and neither did the use of 100 mM sodium citrate 
buffers pH 3 and 3.5. We therefore evaluated the strength of acetate buffer needed to confer the 
necessary driving force for Ig release (Fig. 8). For this, type III magnetic MEP-linked adsorbent 
particles were contacted with 10% (v/v) antiserum at a final support concentration of 24.6 mg mL-1 in 
tenfold diluted serum, washed once with binding buffer at a support concentration of 19.5 mg mL-1 
and then mixed at the same concentration with 50 mM – 1 M sodium acetate buffers, pH 4. 
Immediately post binding the purity of adsorbed Ig registered 52%. Following washing, the adsorbed 
purity increased to nearly 60% at the expense of a 10% loss in yield (indicated in Fig. 8a by data point 
at 0 M sodium acetate). At the lowest sodium acetate concentrations of 0.05 and 0.1 M the first 
elution step selectivity of immunoglobulin elution was high (the purity of desorbed Ig was >93% by 
assay), however the recoveries were poor (<20% and <40% for the 0.05 and 0.1 M sodium acetate 
elution buffers respectively). RSA, the major impurity, is barely visible on reducing SDS-
polyacrylamide gels, representing just 2% of the combined Ig heavy and light chain intensities (Fig. 
8b). Desorption yield increases as the elution buffer strength is raised, but comes at the expense of 
impaired selectivity, emphasized by a roughly linear decline in purity by assay (Fig. 8a) and 
corresponding growth in RSA contamination (reaching >25% of the Ig signal at 1 M sodium acetate) 
and of higher molecular weight species (Fig. 8b). Though a single elution step employing 1 M sodium 
acetate desorbs 91% of the initially adsorbed Ig, all selectivity is lost (Fig. 8a, compare % purities at 0 
and 1 M sodium acetate). A further issue encountered with elution using 1 M sodium acetate elution 
buffer, but not the lower concentrations employed, was the formation of a clear precipitate (most 
likely of lipoprotein4–6) after freezing and thawing the eluates. For these reasons, a sodium acetate 
buffer concentration of 0.5 M was selected for use in subsequent HGMF and small scale purification 
tests, as the best compromise of yield and purity.  
 
Recovery of Ig from rabbit antiserum feedstocks 
Magnetic rack based Ig purification from clarified feed 
Prior to conducting HGMF at larger scale, small magnetic rack based purifications were performed to 
further examine the effects of support concentration during washing and elution on Ig purification 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
performance. Two sets of conditions were employed, i.e. condition ‘A’ – binding and washing at 
support concentration of 30 mg mL-1 and elution at 60 mg mL-1; and condition ‘B’ – binding at a 
support concentration of 24.6 mg mL-1 and washing and elution at 19.5 mg mL-1. Table 2 summarises 
the data obtained and Figure 9 shows the electrophoretic analysis corresponding to condition B.  
In keeping with earlier findings (Figs 5 & 6), the higher support concentration during condition 
A’s binding step resulted in higher Ig binding yield (93.2% of that initially present in the antiserum), 
but lower purity in the adsorbed state (50.6%) cf. condition B (90.1% bound, Purityads= 52.2%). The 
use of a higher support concentration (condition A) during washing also improved the selectivity of 
this step. While very similar amounts of total protein were desorbed in both conditions, the amount of 
bound Ig lost from the supports was >30% lower for condition A (Table 2). Scrutiny of the 
electrophoretogram (Fig. 9, lane 3) for condition B confirms that most of the protein washed from the 
supports was RSA; only a faint trace of Ig is visible. Immediately prior to elution, the Ig yield and 
purity combinations were little different for the two conditions, emphasized by the similarity in 
purification and yield factors at this stage of ~1.85 and ~2.1 for conditions A and B respectively 
(Table 2).  
The biggest impact on purification performance was the support concentration used during 
elution. For condition B (19.5 mg mL-1) two successive elution cycles recovered >92% of the Ig 
remaining bound on supports after washing, leading to an overall Ig recovery of ~80%. Calculated 
desorption efficiencies for the first and second cycles were similarly high (i.e. >75% in first, dropping 
to >68% in the second). Desorption efficiency was markedly reduced when a more than threefold 
higher support concentration (60 mg mL-1) was employed (condition A), falling to 46.9 and 49.7% in 
the first and second cycles respectively. As a result the overall yield registered 66.4%, but the purity 
was not affected (Table 2).  
 
HGMF based Ig purification from unclarified feed 
The limited availability of feedstock constrained the scale at which HGMF could be demonstrated and 
the type of device that could be used, and permitted only a single run to be conducted. The results 
from small scale magnetic rack studies (Table 2) were thus crucial in informing selection of 
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conditions for HGMF from unclarified 10% (v/v) antiserum. The support concentration during 
binding was increased to 31.7 mg mL-1 (cf. 24.6 and 30 mg mL-1 for conditions B and A respectively; 
Table 2), and the adsorbent concentration during the wash and elution steps was 23.5 mg mL-1. The 
same binding and elution times were employed (i.e. 600 s in both cases), but given the presence of 
solids in the unclarified antiserum feed and to ensure efficient particle release from the magnetic 
filter, the duration of the single wash cycle was raised from 30 to 60 s. Table 3 summarises the results 
obtained and Fig. 10 displays the corresponding SDS-PAGE analysis of fractions from the run.  
In general, it is clear that purification transferred successfully from magnetic rack (Table 2) to 
HGMF operation (Table 3) and that the added presence of suspended solids in the unclarified 
antiserum did not perturb overall Ig purification performance, as the combined yield of >72% from 
two elution cycles was similar and the calculated Ig purity of 81% was slightly higher than that 
achieved in smaller scale tests with the clarified antiserum feedstock. Closer scrutiny of the data 
obtained at each sub-step however, highlights differences arising from the feedstock (i.e. unclarified 
vs clarified) and/or magnetic particle separation mode (i.e. magnetic filter vs magnetic rack) 
employed.  
The slightly higher support concentration employed during binding resulted in capture of >95% 
of the Ig from the unclarified antiserum (Table 3); but this small gain was offset by a larger increase 
in the amount of protein adsorbed onto the supports (i.e. to nearly 60% cf. 51 – 52%), thus the 
calculated purity in adsorbed state prior to washing was just 43% cf. 51 – 52% observed in the smaller 
scale magnetic rack experiments conducted with the clarified feed (Table 2). After washing, the 
amount of protein adsorbed on the support dropped significantly (to 52%), but not to the level 
expected from smaller scale magnetic rack conducted with clarified antiserum (i.e. 41 – 44%), while 
the amount of adsorbed Ig lost into the wash increased to 4.7% (Table 3). Both effects likely stem 
from ‘additional’ surface fouling from extra components in suspended solids in unclarified feed. The 
selectivity of Ig desorption from supports during elution in HGMF was not affected by the increased 
level of competing species adsorbed on the non-porous surfaces of the magnetic MEP-linked 
adsorbent particles (compare entries for % eluted of firmly bound, purity and purification factor in 
Table 3 with those in Table 2).  
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The banding patterns observed in the electrophoretogram of HGMF fractions (Fig. 10) are 
qualitatively very similar to those from the small scale condition B (Fig. 9) and are entirely consistent 
with the process data in Table 3. Bands for Ig cannot be detected in lane 2 (flow through) and the 
intensity of the RSA band is much reduced cf. lane 1 (starting material). A strong RSA band intensity 
is restored in lane 3 (wash) accompanied by faint heavy and light chain Ig bands. The relative 
intensities of RSA and Ig bands are reversed in lanes 4 and 5 respectively corresponding to the first 
and second cycles of elution.  
Calculated Ig desorption efficiencies (59.2% for the first elution dropping to 50.5% for the 
second) were lower than expected from small scale studies conducted with the ‘cleaner’ clarified feed 
(see above). Nearly 80% of the firmly bound Ig was retrieved by these two HGMF elution cycles 
(Table 3), but attempts to recover ‘missing’ Ig remaining bound on supports proved unsatisfactory. 
While four additional cycles dislodged a further 2.15 mg of Ig (8.2% of that firmly bound prior to 
elution), boosting the overall Ig yield from 72.4% to 79.9%, Ig purity fell to 60.2% because an extra 
12.3 mg of protein (22% of that firmly bound prior to elution) was desorbed from the supports. After 
the last elution cycle had been completed, the ‘charge’ of magnetic particles within the HGMF system 
was flushed out and the filter was dismantled for cleaning. Visual inspection of the unrolled filter 
matrix confirmed the trace presence of magnetic particles, but no biological fouling material was 
evident.  
 
Limitations of HGMF system employed 
The main advantage of the mini-pilot scale cyclically operated ‘ON–OFF’ permanent magnet based 
HGMS used in this work is that allows demonstration of the HGMF concept with small volumes of 
feedstock. Despite the inherent novelty of its design, it does not reflect the current ‘state-of-the-art’. In 
common with earlier studies19,20,22–26,41,42 the system used in this work employs a canister packed with 
of a matrix of ferromagnetic wires and an extracorporeal recycle loop for conducting washing and 
elution cycles when the field is switched ‘OFF’. While this design is capable of delivering high 
particle separation efficiencies from complex feed streams and affords powerful demonstrations of the 
processing speed and capabilities of HGMF for recovering candidate protein targets from highly 
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complex unclarified bioprocess feedstocks, as illustrated in this study, it does not lend itself to multi-
cycle operation26 and potential exploitation at large-scale.15,21  
Two weaknesses of the ‘fixed filter matrix + recycle loop’ device are apparent from the work 
conducted here. First, the much higher product and support concentrations employed in this work cf. 
previous studies,18,20,23–26,41,42 rendered concentration on elution impossible. Loading of the ‘feedstock 
+ particle’ cocktail into the filter took just 25 s. Though particles were concentrated nearly threefold 
within the filter, following two steps of elution, which recovered 80% of the adsorbed Ig, the 
combined eluate’s Ig concentration was 3.7 fold more dilute than that of the feed (i.e. 0.67 cf. 2.5 mg 
mL-1). Second, in the ‘fixed filter matrix + recycle loop’ design, adsorbents are flushed out of the filter 
matrix and mixed with eluant by recirculating the resulting suspension at high velocity around the 
canister–loop circuit. For product elution from the adsorbent particles to be effective, efficient particle 
release from matrix wires must occur. The reduced elution efficiency identified above, combined with 
detection of adsorbent particles within the filter at the end of the experiment, point to incomplete 
particle release.  
 
Rotor-stator HGMS 
The aforementioned problems, additional related issues and requirements for automated multicycle 
operation and cGMP compliance have driven the development of the automated rotors-stator 
magnetic filters.9,15,21,27 Rotor-stator HGMS devices feature two sets of alternating perforated stainless 
steel filter discs – one set can be rotated at high speed and the other is stationary. The design is highly 
effective at re-slurrying attached magnetic particles at zero field, affords high particle collection 
capacities (>200 g per litre of filter) and continuous multi-cycle operation without loss in performance 
from one operating cycle to the next. All washing and elution steps are conducted within the 
separator, eliminating the need for extracorporeal recycle loops or external vessels, leading to reduced 
buffer consumption, simpler and faster operation. Against the above, it is reasonable to conclude that 
had a modern rotor-stator HGMS been employed to recover and process product laden type III MEP-
linked magnetic adsorbents from the same feedstock, all aspects of Ig purification performance by 
HGMF would have markedly improved.  
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Conclusions  
An HGMF process for the recovery of rabbit Ig from unclarified antiserum using MEP-linked non-
porous superparamagnetic adsorbents has been developed. Unconditioned ultra-high titre bioprocess 
liquors present stern challenges to adsorptive separation techniques, and though specifically designed 
for capture from crude complex feeds, HGMF is not immune to these. To recover >90% of the Ig 
present in raw unclarified serum (25 g Ig per L; 93 g protein per L) would require ~0.3 g type III 
MEP- linked adsorbent per mL, which is roughly threefold higher than both the adsorbent holding 
capacity of the magnetic filter used in this work and the support’s sediment density.48 Because of this 
antiserum was diluted tenfold bringing the target Ig titre to 2.5 g L-1, a level similar to that of 
monoclonal antibody containing culture broths.12 Greater than 95% of the Ig present in this unclarified 
feed was adsorbed at a working Ig binding capacity of 75 mg g-1, and after a brief washing step 80% 
of the bound Ig was recovered in two elution cycles in more than threefold purified form (81% 
uncorrected; 90% corrected) appropriate for immunodiagnostic use. The whole process took 0.5 h, but 
considerable time savings (principally by reducing the binding time) are clearly possible without 
sacrificing purification performance.  
To cope with higher Ig titres found in animal sera, human plasma and highly expressing CHO 
cultures, more selective adsorption is required to make full use of the available surface area for target 
binding (ca. 200 – 250 mg g-1 with present magnetic support design) thereby reducing the amounts of 
magnetic support required to treat a given feed. This could be achieved either through the prior and/or 
post addition of sodium caprylate39,47 to reduce serum albumin adsorption (the potential downsides 
here are reduced Ig yield and compromised isolation of other targets), boosting the immobilised 
ligand density – perhaps through grafting of ligand-bearing polymers or dendrons,15,49 and/or use of a 
more potent ‘capture’ ligands.12,36  
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Table 1. Comparison of MEP linked support types I – IV (see Fig. 1) for the recovery of immunoglobulins from 20% (v/v) clarified rabbit antiserum (see text 
for details). 
     
Support 
ID 
Activation 
method 
Binding  Elution 
Ig bound 
(%) 
Total protein 
bound (%) 
Q*Ig 
(mg g-1) 
Q*Total protein 
(mg g-1) 
Adsorbed Ig 
purity (%)* 
PFads*  Ig yield 
(%) 
Ig purity 
(%)* 
PF** 
Type I ECH 25.4 19.8 181 527 34.35 1.28  12.55 91.7 3.41 
Type II AB 5.6 13.1 40 347 11.53 0.43  2.93 63.9 2.38 
Type III AGE 23.8 11.4 170 303 56.11 2.09  13.7 95.0 3.53 
Type IV DVS 12.5 18.1 89 480 18.54 0.69 10.82 83.3 3.10
*PFads = purification factor for the adsorption step and **PF = overall purification factor. 
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Table 2. Summary of data for magnetic rack based recovery of Ig from clarified rabbit antiserum (10% v/v) using type III MEP-linked magnetic adsorbents. 
Two sets of conditions (A & B) were investigated.  
 
Condition A: Support concentration of 30 mg mL-1 during binding and washing and 60 mg mL-1 during elution 
 
Recovery step Ig (mg) Protein (mg) Purity (%) Ig yield (%) Protein yield (%) PF (-)* YF (-)**
Antiserum  3.95 14.19 27.8 100 100 1.0 1.0 
Unbound 0.27 6.93 3.9 6.8 48.8   
Bound 3.68 7.26 50.6 93.2 51.2 1.82 1.70 
Wash 0.10 1.00 10.0 2.5 7.0   
Elution 1 1.68 2.27 73.7 42.5 16.0 2.65  
Elution 2 0.94 1.24 75.8 23.9 8.8 2.73  
Combined elutions 2.62 3.52 74.4 66.4 24.8 2.68 1.78 
        
Mass balance (%) 75.7 80.7      
Elution efficiency (%) 73.2 56.2     - 
 
Condition B: Support concentration of 24.6 mg mL-1 during binding and 19.5 mg mL-1 during washing and elution 
 
Recovery step Ig (mg) Protein (mg) Purity (%) Ig yield (%) Protein yield (%) PF (-)* YF (-)** 
Antiserum  3.95 14.19 27.8 100 100 1.0 1.0 
Unbound 0.39 7.38 5.3 9.9 52.0
Bound 3.56 6.81 52.2 90.1 48.0 1.88 1.69 
Washes 0.13 0.98 13.6 3.4 6.9   
Elution 1 2.57 3.44 74.9 65.2 24.2 2.68  
Elution 2 0.58 0.77 75.0 14.7 5.4 2.70  
Combined elutions 3.15 4.21 74.9 79.9 29.6 2.68 2.14 
        
Mass balance (%) 93.3 88.6      
Elution efficiency (%) 92.1 72.2      
* PF = overall purification factor and ** YF = yield factor. 
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Table 3. Summary of data for HGMF based recovery of Ig from unclarified rabbit antiserum (10% v/v) using type III MEP-linked magnetic adsorbents. The 
concentration of supports particles employed during binding was 31.7 mg mL-1 during binding and was 23.5 mg mL-1 during washing and elution. 
 
Recovery step Ig (mg) Protein (mg) Purity (%) Ig yield (%) Protein yield (%) PF (-)* YF (-)** 
        
Antiserum  28.7 107.6 26.67 100 100 1.0 1.0 
Flow through (unbound)  1.35 43.52 3.10 4.7 40.4   
Bound 27.35 64.08 42.7 95.3 59.6 1.60 1.52 
Wash 1.35 8.29 16.3 4.7 7.7   
Elution 1 15.40 19.01 81.0 53.6 17.7 3.04
Elution 2 5.38 6.70 80.3 18.7 6.2 3.01  
Combined elutions 20.78 25.71 80.8 72.4 23.9 3.03 2.19 
        
Mass balance (%) 81.8 72.0      
Elution efficiency (%) 79.9 46.1      
*PF = overall purification factor and ** YF = yield factor.  
 
 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
  
 
 
Figure 1. Scheme for the manufacture of the 4-MEP linked magnetic supports used in this study. Key: ai 
NaOH, rt; aii washing (water → NaCl → methanol), rt; bi 3-aminopropyltriethoxysilane, glacial acetic acid, 
methanol, 600 s @ 13,000 rpm → 2 h @ 6,000 rpm, rt; bii glycerol, N2, 11 h @ 110 °C, 0.5 h @ 160 °C; biii 
washing (water → NaCl → water), rt; ci glutaraldehyde, pH 11, 1 h, rt; cii washing (water → NaCl → water); 
d epichlorohydrin, NaOH, NaBH4, 6 h, rt; e allyl bromide, NaOH, NaBH4, DMSO, 18 – 20 h, rt; f allyl glycidyl 
ether, NaOH, NaBH4, DMSO, 18 – 20 h, rt; g divinylsulphone, Na2CO3, 1 h, rt; h N-bromosuccinimide, 1 h, 
rt; j 4-mercaptoethyl pyridine hydrochloride, Na2CO3, NaBH4, 48 h, rt.  
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Figure 2. Schematic representation of the HGMF system employed. Key: batch adsorption reactor (BAR); 
magnetic filter (MF); fraction collector (FC); valves (V1-V5); pumps (P1 & P2); wash buffer (WB); elution 
buffer (EB).  
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Figure 3. Reducing SDS-PAGE analysis of eluates from MEP-linked supports obtained during Ig recovery 
from clarified rabbit antiserum. Key: molecular weight markers (M); rabbit antiserum (1); eluates from MEP 
support types I (2), II (3), III (4) and IV (5); RSA = rabbit serum albumin; Ig = immunoglobulin; HC = 
heavy chain; LC = light chain.  
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Figure 4. Optimisation of conditions (a – time, b – pH, c – conductivity) for the binding of rabbit Ig from 
clarified 10% (v/v) antiserum on type III MEP linked magnetic adsorbent particles (fixed support 
concentration = 8.5 mg mL-1). Key: % bound Ig (white squares); % bound protein (black squares); % 
Purityads (grey up-triangles). The large and small symbols used in plot c are for data obtained with ‘added 
NH4(SO4)2’ and ‘added NaCl’ respectively.  
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Figure 5. Effect of varying (a) antiserum strength (fixed support concentration = 4.6 mg mL-1) and (b) 
support concentration (fixed 10.2% v/v antiserum feed) on Ig and total protein binding of type III MEP-
linked magnetic adsorbents. Key: % bound Ig (white squares); % bound total protein (black squares); Ig 
binding capacity (white circles); total protein binding capacity (black circles).  
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Figure 6. Impact of antiserum/support ratio on the binding performance of type III MEP-linked adsorbents. 
Key: (a) % bound Ig (white squares), % bound total protein (black squares), Ig binding capacity (white 
squares), total protein binding capacity (black squares); (b) fractional Ig yield (solid line), purification factor 
on adsorption (PFads, dashed line), yield factor on adsorption (YFads, dotted line).  
 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
For Peer Review
  
 
 
Figure 7. (a) Equilibrium adsorption of Ig (white circles) and total protein (black circles) from clarified rabbit 
antiserum on type III MEP-linked magnetic particles. (b) Protein desorbed by washing post binding (grey 
circles) as a function of total protein binding capacity (Q*Total Protein). The broken line through Ig data in (a) 
represents the fit of the Langmuir model (eq 1) with the parameters Qmax = 213.7 ± 18.7 mg g
-1 and Kd = 
0.085 ± 0.04 mg mL-1.  
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Figure 8. Effect of sodium acetate pH 4 buffer concentration on the (a) desorption of bound rabbit Ig and 
total protein from washed type III MEP linked magnetic adsorbents in a single elution cycle and (b) 
corresponding SDS-PAGE analysis. The support concentration during binding was 24.6 mg mL-1 and was 
reduced to 19.5 mg mL-1 for washing and elution. The amounts of Ig and total protein released are 
expressed as percentages of the total bound prior to elution. Key: desorbed Ig (white up-triangles), 
desorbed protein (black up-triangles); Ig purity (grey up-triangles).  
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Figure 9. Reducing SDS-PAGE analysis of ‘Table 2 Condition B’ samples arising from magnetic rack based Ig 
recovery from clarified 10% (v/v) rabbit antiserum using type III MEP linked magnetic supports. Key: 
molecular weight markers (M); rabbit antiserum (1); unbound (2); wash (3); elution 1 (4); elution 2 (5); 
RSA = rabbit serum albumin; Ig = immunoglobulin; HC = heavy chain; LC = light chain.  
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Figure 10. Reducing SDS-PAGE analysis of ‘Table 3’ samples arising from HGMF based Ig recovery from 
unclarified 10% (v/v) rabbit antiserum using type III MEP linked magnetic supports. Key: molecular weight 
markers (M); rabbit antiserum (1); flow through (2); wash (3); elution 1 (4); elution 2 (5); RSA = rabbit 
serum albumin; Ig = immunoglobulin; HC = heavy chain; LC = light chain.  
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